Literature DB >> 9847492

Intranasal abuse of prescribed methylphenidate.

E J Garland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9847492     DOI： 10.1097/00004583-199812000-00003

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  6 in total

1.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.

Authors:  C Poulin
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

2.  Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Authors:  Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly
Journal:  J Clin Pharmacol       Date:  2010-07-29       Impact factor: 3.126

3.  Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats.

Authors:  Michelle G Baladi; Shannon M Nielsen; Anthony Umpierre; Glen R Hanson; Annette E Fleckenstein
Journal:  Behav Pharmacol       Date:  2014-12       Impact factor: 2.293

4.  Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Joseph English; Rachel Robinson; Matt Hallyburton; Allan K Chrisman
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

5.  Acute and chronic dose-response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior.

Authors:  Zachary Jones; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2013-11-20       Impact factor: 3.575

Review 6.  A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder.

Authors:  Himanshu P Upadhyaya; Durisala Desaiah; Kory J Schuh; Frank P Bymaster; Mary J Kallman; David O Clarke; Todd M Durell; Paula T Trzepacz; David O Calligaro; Eric S Nisenbaum; Paul J Emmerson; Leslie M Schuh; Warren K Bickel; Albert J Allen
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.